De Maria Marchiano, Ruggero
 Distribuzione geografica
Continente #
NA - Nord America 12.650
EU - Europa 8.438
AS - Asia 3.249
AF - Africa 23
SA - Sud America 20
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 8
Totale 24.402
Nazione #
US - Stati Uniti d'America 12.620
PL - Polonia 3.408
CN - Cina 1.921
SE - Svezia 1.828
IT - Italia 880
IE - Irlanda 640
SG - Singapore 464
DE - Germania 397
RU - Federazione Russa 274
GB - Regno Unito 257
VN - Vietnam 243
TR - Turchia 241
IN - India 189
FR - Francia 187
UA - Ucraina 162
AT - Austria 144
FI - Finlandia 69
HK - Hong Kong 66
JP - Giappone 42
BE - Belgio 38
CH - Svizzera 29
IR - Iran 24
ES - Italia 23
NL - Olanda 22
RO - Romania 18
CA - Canada 14
BG - Bulgaria 12
BR - Brasile 11
CI - Costa d'Avorio 10
EU - Europa 10
AU - Australia 8
CZ - Repubblica Ceca 8
KR - Corea 8
PA - Panama 8
SA - Arabia Saudita 8
NO - Norvegia 7
PT - Portogallo 6
BA - Bosnia-Erzegovina 5
IL - Israele 5
LU - Lussemburgo 5
PK - Pakistan 5
SC - Seychelles 5
TW - Taiwan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
BZ - Belize 3
CO - Colombia 3
GE - Georgia 3
HU - Ungheria 3
IQ - Iraq 3
LK - Sri Lanka 3
AR - Argentina 2
CL - Cile 2
CM - Camerun 2
DK - Danimarca 2
GR - Grecia 2
HR - Croazia 2
ID - Indonesia 2
KE - Kenya 2
MD - Moldavia 2
MX - Messico 2
MY - Malesia 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AL - Albania 1
BD - Bangladesh 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
LT - Lituania 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
TT - Trinidad e Tobago 1
ZA - Sudafrica 1
Totale 24.402
Città #
Warsaw 3.391
Chandler 1.621
Fairfield 1.488
Ashburn 970
Redmond 767
Wilmington 729
Woodbridge 693
Houston 666
Dublin 640
Seattle 633
Cambridge 507
Nanjing 482
Princeton 344
Ann Arbor 335
Hangzhou 310
Boston 288
Singapore 272
San Mateo 244
Dong Ket 242
Beijing 209
Dearborn 205
Izmir 202
Jacksonville 200
Cattolica 188
Nanchang 180
Moscow 169
Rome 143
Vienna 142
New York 131
Chicago 122
Milan 103
Shenyang 94
San Diego 84
London 80
Bremen 75
Tianjin 75
Norwalk 74
Hebei 72
Redwood City 69
Kunming 65
Mountain View 60
Hong Kong 59
Los Angeles 53
Jiaxing 52
Marseille 52
Phoenix 44
Brussels 38
Changsha 36
Helsinki 33
Andover 30
Guangzhou 29
Lawrence 28
Boardman 27
Chiswick 27
Augusta 24
Kocaeli 24
Jinan 23
Springfield 21
Kish 18
Pune 17
Gloucester 16
Edinburgh 15
Lanzhou 15
Shanghai 15
Washington 15
Zurich 15
Changchun 14
Fort Worth 14
Hounslow 14
Forest City 13
Acton 12
Donostia / San Sebastian 11
Falls Church 11
Kraków 11
Abidjan 10
Gunzenhausen 10
Gurgaon 10
Leawood 10
Providence 10
Sofia 10
Zhengzhou 10
Munich 9
Tokyo 9
Kilburn 8
Lancaster 8
San Francisco 8
Stockholm 8
Bern 7
Fuzhou 7
Orange 7
Palermo 7
Prineville 7
Sandston 7
Seoul 7
São Paulo 7
Sète 7
Timisoara 7
Amsterdam 6
Busto Arsizio 6
Dallas 6
Totale 18.398
Nome #
CHK1-targeted therapy to deplete DNA replication- stressed, p53-deficient, hyperdiploid colorectal cancer stem cells 352
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes 308
Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy 300
Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterations 299
Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer 292
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 273
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real- world experience 267
Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer 261
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer 253
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 251
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer 251
Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells. 243
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma 242
Two-Step Co-Immunoprecipitation (TIP) Enables Efficient and Highly Selective Isolation of Native Protein-Complexes. 238
Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications 236
Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer 235
A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology 231
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 231
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma 229
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies 228
Alliance Against Cancer, the network of Italian cancer centers bridging research and care 228
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer 227
miR-663 sustains NSCLC by inhibiting mitochondrial outer membrane permeabilization (MOMP) through PUMA/ BBC3 and BTG2 226
Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance 226
miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal 222
Replication stress in colorectal cancer stem cells 222
Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer 222
Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy 220
Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis 218
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer 218
Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study 213
Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes with Different Clinical Outcome 213
(1)H NMR detects different metabolic profiles in glioblastoma stem-like cells 213
Protein drug target activation homogeneity in the face of intra- tumor heterogeneity: implications for precision medicine 210
The Hippo pathway in normal development and cancer 205
DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy 203
DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy 203
Analysis of the ATR-Chk1 and ATM- Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression 202
Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression 202
Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer 199
Colorectal cancer: towards new challenges and concepts of preventive healthcare 199
HMG-CoAR expression in male breast cancer: Relationship with hormone receptors, Hippo transducers and survival outcomes 188
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 181
Gene Expression Analysis of PTEN Positive Glioblastoma Stem Cells Identifies DUB3 and Wee1 Modulation in a Cell Differentiation Model 177
A BMP7 variant inhibits tumor angiogenesis in vitro and in vivo through direct modulation of endothelial cell biology 162
DNA damage and repair biomarkers in cervical cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis 160
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015 156
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience 155
Antisense RNA for Treating Cancer and Inhibition of Metastasis and Vectors for Antisense Sequestration 146
1H NMR spectroscopy of glioblastoma stem‐like cells identifies alpha‐aminoadipate as a marker of tumor aggressiveness 140
A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer 136
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go 131
Inhibitor of integrin for the treatment or prevention of tumours 129
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant 125
“Triple positive” early breast cancer: an observational multicenter retrospective analysis of outcome 114
Alliance Against Cancer, the network of Italian cancer centers bridging research and care 108
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 104
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 102
C-Met/MIR-130b axis as novel mechanism and biomarker for castration resistance state acquisition 101
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis. 98
C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition 97
C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition 96
HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome 95
Integrin a7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 94
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells 94
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo 93
Essential versus accessory aspects of cell death: Recommendations of the NCCD 2015 92
Pluripotency and differentiation in embryos and stem cells 92
Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression 87
Epithelial-mesenchymal transition: a new target in anticancer drug discovery 85
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin 84
Antitumor effect of miR-197 targeting in p53 wild-type lung cancer 83
Two-Step Coimmunoprecipitation (TIP) enables efficient and highly selective isolation of native protein complexes 80
Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome 79
The targeting of mre11 or rad51 sensitizes colorectal cancer stem cells to chk1 inhibition 79
Two-Step Co-Immunoprecipitation (TIP) 78
Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer 75
BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition 74
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo 74
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 74
A real-time integrated framework to support clinical decision making for covid-19 patients 74
Differentiation affects the release of exosomes from colon cancer cells and their ability to modulate the behavior of recipient cells 73
Gene expression analysis of PTEN positive glioblastoma stem cells identifies DUB3 and Wee1 modulation in a cell differentiation model 73
Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells 73
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 72
Nobiletin and xanthohumol sensitize colorectal cancer stem cells to standard chemotherapy 72
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response 71
Blocking the APRIL circuit enhances acute myeloid leukemia cell chemosensitivity 71
A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells 71
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo 70
1H NMR spectroscopy of glioblastoma stem-like cells identifies alpha-aminoadipate as a marker of tumor aggressiveness 70
Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer 70
1H NMR detects different metabolic profiles in glioblastoma stem-like cells 69
Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51 68
EGFR Inhibition Abrogates Leiomyosarcoma Cell Chemoresistance through Inactivation of Survival Pathways and Impairment of CSC Potential 67
"Triple positive" early breast cancer: An observational multicenter retrospective analysis of outcome 66
Protein drug target activation homogeneity in the face of intra-tumor heterogeneity: implications for precision medicine 64
The inhibition of the highly expressed mir-221 and mir-222 impairs the growth of prostate carcinoma xenografts in mice 64
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 63
Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy 62
Totale 15.412
Categoria #
all - tutte 113.044
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.044


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.359 0 0 713 1.526 312 438 690 319 435 192 567 167
2020/20212.991 257 323 199 149 406 195 477 73 238 217 170 287
2021/20222.787 260 264 126 131 162 145 72 414 132 124 472 485
2022/20235.115 756 695 466 547 372 642 111 447 667 124 200 88
2023/20242.710 101 908 85 128 114 213 199 83 30 84 342 423
2024/2025344 225 119 0 0 0 0 0 0 0 0 0 0
Totale 24.914